TP53-Mutant Variant Allele Frequency and Cytogenetics Determine Prognostic Groups in MDS/AML for Transplantation

The authors analyzed 240 patients with TP53-mutated myelodysplastic syndrome (MDS) or AML who underwent HSC transplantation.